O P Malik

Patient Name : O P Malik 8348215985 Barcode : H9091540
Age/Gender : 83Y 0M 0D /Male Sample Collected On : 24/Jun/2023 08:04AM

Order Id : 8348215985 Sample Received On : 24/Jun/2023 04:22PM
Referred By : Self Report Generated On : 24/Jun/2023 07:17PM
Customer Since : 24/Jun/2023 Sample Temperature : Maintained
Sample Type : Whole Blood EDTA Report Status : Final Report
DEPARTMENT OF BIOCHEMISTRY HBA1C

Test Name Value Unit Bio. Ref Interval
HbA1c - Glycosylated Hemoglobin

Hba1c (Glycosylated Hemoglobin) 6.20 % 4.2 - 5.7
Method: HPLC
Average Estimated Glucose - plasma 131.24 mg/dl
Method: Calculated
INTERPRETATION:
AS PER AMERICAN DIABETES ASSOCIATION (ADA):
REFERENCE GROUP GLYCOSYLATED HEMOGLOBIN (HBA1c) in %
Non diabetic <5.7
At Risk (Prediabetes) 5.7 – 6.4
Diagnosing Diabetes >= 6.5
Age > 19 Years
Goals of Therapy: < 7.0
Actions Suggested: >8.0
Therapeutic goals for glycemic control Age < 19 Years
Goal of therapy: <7.5
REMARKS
1. HbA1c is used for monitoring diabetic control. It reflects the mean plasma glucose over three months
2. HbA1c may be falsely low in diabetics with hemolytic disease. In these individuals a plasma fructosamine level may be used which evaluates diabetes over 15
days.
3. Inappropriately low HbA1c values may be reported due to hemolysis, recent blood transfusion, acute blood loss, hypertriglyceridemia, chronic liver disease. Drugs
like dapsone, ribavirin, antiretroviral drugs, trimethoprim, may also cause interference with estimation of HbA1c, causing falsely low values.
4. HbA1c may be increased in patients with polycythemia or post-splenectomy.
5. Inappropriately higher values of HbA1c may be caused due to iron deficiency, vitamin B12 deficiency, alcohol intake, uremia, hyperbilirubinemia and large doses of
aspirin.
6. Trends in HbA1c are a better indicator of diabetic control than a solitary test. 7. Any sample with >15% HbA1c should be suspected of having a hemoglobin
variant, especially in a non-diabetic patient. Similarly, below 4% should prompt additional studies to determine the possible presence of variant hemoglobin.
8. HbA1c target in pregnancy is to attain level <6 % .
9. HbA1c target in paediatric age group is to attain level < 7.5 %.
Method : Ion-exchange high-performance liquid chromatography (HPLC).
Reference : American Diabetes Associations. Standards of Medical Care in Diabetes 2023
Page 1 of 9
SIN No:H9091540
Sample Type : Flouride Plasma Report Status : Final Report
DEPARTMENT OF BIOCHEMISTRY
Fasting Blood Sugar

Glucose, Fasting 82.3 mg/dl 70 - 100
Method: Hexokinase
American Diabetes Association Reference Range :
Normal : < 100 mg/dl

Impaired fasting glucose(Prediabetes) : 100 - 126 mg/dl
Diabetes : >= 126 mg/dl
Conditions that can result in an elevated blood glucose level include: Acromegaly, Acute stress (response to trauma, heart attack, and stroke for instance), Chronic
kidney disease, Cushing syndrome, Excessive consumption of food, Hyperthyroidism, Pancreatitis
A low level of glucose may indicate hypoglycemia, a condition characterized by a drop in blood glucose to a level where first it causes nervous system symptoms
(sweating, palpitations, hunger, trembling, and anxiety), then begins to affect the brain (causing confusion, hallucinations, blurred vision, and sometimes even coma
and death). A low blood glucose level (hypoglycemia) may be seen with:Adrenal insufficiency, Drinking excessive alcohol, Severe liver disease, Hypopituitarism,
Hypothyroidism, Severe infections, Severe heart failure, Chronic kidney (renal) failure, Insulin overdose, Tumors that produce insulin (insulinomas), Starvation.
Page 2 of 9
SIN No:H9091540
Sample Type : SERUM Report Status : Final Report
Lipid Profile 1.0

Total Cholesterol 174 mg/dl Desirable : <200
Method: Enzymatic Borderline: 200-239
High : >/=240
Serum Triglycerides 239 mg/dl Desirable : <150
Method: Enzymatic Borderline high : 150-199
High : 200-499
Very high : >= 500
Serum HDL Cholesterol 31.7 mg/dl 40 - 60
Method: Enzymatic immuno inhibition
Serum LDL Cholesterol 94.5 mg/dl Optimal : <100
Method: Calculated near /above Optimal:100 -
129
Borderline High:130 - 159
High : 160 - 189
Very High :>/=190
Serum VLDL Cholesterol 47.8 mg/dl 06 - 30
Method: Calculated
Total CHOL / HDL Cholesterol Ratio 5.49 Ratio 3.30 - 4.40
Method: Calculated
LDL / HDL Cholesterol Ratio 2.98 Ratio Desirable/Low Risk: 0.5-3.0
Method: Calculated Line/Moderate Risk: 3.0-6.0
Elevated/High Risk: >6.0
HDL / LDL Cholesterol Ratio 0.34 Ratio Optimal->0.4
Method: Calculated Moderate-0.4 to 0.3
High-<0.3
Page 3 of 9
SIN No:H9091540
Liver Function Test 1.0

Serum Bilirubin, (Total) 0.50 mg/dl 0.3 - 1.2
Method: Diazo
Serum Bilirubin, (Direct) 0.08 mg/dl 0 - 0.2
Method: Diazo
Serum Bilirubin, (Indirect) 0.42 mg/dl 0.0 - 0.8
Method: Calculated
Aspartate Aminotransferase (AST/SGOT) 21.40 U/L 3- 50
Method: IFCC
Alanine Aminotransferase (ALT/SGPT) 17.90 U/L 3 - 50
Method: IFCC
Alkaline Phosphatase (ALP) 65.60 U/L 43 - 115
Method: IFCC AMP Buffer
Serum Total Protein 6.40 g/dl 6.6 - 8.3
Method: Biuret
Serum Albumin 3.80 g/dl 3.5 - 5.2
Method: Bromo Cresol Green(BCG)
Serum Globulin 2.60 gm/dl 3.0 - 4.2
Method: Calculated
Albumin/Globulin Ratio 1.46 Ratio 1.2 - 2.5
Method: Calculated
Page 4 of 9
SIN No:H9091540
Kidney Function Test 1.0

Serum Creatinine 1.10 mg/dl 0.7 - 1.3
Method: Jaffes Kinetic
Serum Uric Acid 6.2 mg/dl 3.5-7.2
Method: Uricase
Serum Calcium 8.8 mg/dl 8.8 - 10.6
Method: Arsenazo
Serum Sodium 144 mmol/L 136 - 146
Method: ISE Direct
Serum Potassium 4.55 mmol/L 3.5 - 5.1
Method: ISE Direct
Serum Chloride 109 mmol/L 98 - 107
Method: ISE Direct
Blood Urea 41 mg/dl 17 - 43
Method: Urease
Blood Urea Nitrogen (BUN) 19.0 mg/dl 8-20
Method: Calculated
The kidneys play a vital role in the excretion of waste products and toxins such as urea, creatinine and uric acid, regulation of extracellular fluid
volume, serum osmolality and electrolyte concentrations, as well as the production of hormones like erythropoietin and 1,25 dihydroxy vitamin D
and renin. Assessment of renal function is important in the management of patients with kidney disease or pathologies affecting renal function.
Tests of renal function have utility in identifying the presence of renal disease, monitoring the response of kidneys to treatment, and determining
the progression of renal disease.
Urea is synthesized in the liver as the final product of protein and amino acid metabolism. Urea synthesis is therefore dependent on daily protein
intake and endogenous protein metabolism.
Creatinine is a metabolic product of creatine and phosphocreatine, which are both found almost exclusively in muscle.
Uric Acid is the major product of purine catabolism in humans. Uric acid levels are used to monitor the treatment of gout.
Measurement of calcium is used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease,
urolithiasis and tetany. Phosphorus levels are increased in acute or chronic renal failure with decreased GFR .
Sodium is an electrolyte, and it helps regulate the amount of water in and around the cells & the balance of chemicals in the body called acids
and bases. Potassium is a primary intracellular ion, only 2 % is extracellular, high intracellular concentration is maintained by a Na- K ATPase
pump, which continuously transports potassium into the cell against a concentration gradient. Chloride is a negatively charged ion that works
with other electrolytes such as potassium, sodium, and bicarbonate, to help regulate the amount of fluid in the body and maintain the acid-base
balance.
Page 5 of 9
SIN No:H9091540
DEPARTMENT OF HAEMATOLOGY
Complete Haemogram
Haemoglobin (HB) 14.1 g/dL 13.0-17.0
Method: Photometric Measurement
Total Leucocyte Count (TLC) 7.7 10^3/uL 4.0-10.0
Method: Coulter Principle
Hematocrit (PCV) 42.9 % 40.0-50.0
Method: Calculated
Red Blood Cell Count (RBC) 5.56 10^6/µl 4.50-5.50
Mean Corp Volume (MCV) 77.1 fL 83.0-101.0
Method: Derived from RBC Histogram
Mean Corp Hb (MCH) 25.3 pg 27.0-32.0
Method: Calculated
Mean Corp Hb Conc (MCHC) 32.8 g/dL 31.5-34.5
Method: Calculated
RDW - CV 18.0 % 11.6-14.0
RDW - SD 44.90 fL 39.0-46.0
Mentzer Index 13.87 Ratio
Method: Calculated
RDWI 249.60 Ratio
Method: Calculated
Green and king index 76 Ratio
Method: Calculated
Differential Leucocyte Count
Neutrophils 54.4 % 40 - 80
Method: Optical/Impedence
Lymphocytes 32.64 % 20-40
Monocytes 7.6 % 02 - 10
Eosinophils 4.8 % 01 - 06
Basophils 0.5 % 00 - 02
Page 6 of 9
SIN No:H9091540
DEPARTMENT OF HAEMATOLOGY
Absolute Leucocyte Count
Absolute Neutrophil Count (ANC) 4.19 10^3/uL 2.0-7.0
Method: Calculated
Absolute Lymphocyte Count (ALC) 2.51 10^3/uL 1.0-3.0
Method: Calculated
Absolute Monocyte Count 0.58 10^3/uL 0.2-1.0
Method: Calculated
Absolute Eosinophil Count (AEC) 0.37 10^3/uL 0.02-0.5
Method: Calculated
Absolute Basophil Count 0.04 10^3/uL 0.02 - 0.10
Method: Calculated
Platelet Count(PLT) 154.5 10^3/µl 150-410
MPV 10.7 fL 7-9
Method: Derived from PLT Histogram
ESR 4 mm/1st hour 0-30
Method: Modified Westergren Method
The International Council for Standardization in Haematology (ICSH) recommends reporting of absolute counts of various WBC subsets for clinical decision making.
This test has been performed on a fully automated 5 part differential cell counter which counts over 10,000 WBCs to derive differential counts. A complete blood
count is a blood panel that gives information about the cells in a patient's blood, such as the cell count for each cell type and the concentrations of Hemoglobin and
platelets. The cells that circulate in the bloodstream are generally divided into three types: white blood cells (leukocytes), red blood cells (erythrocytes), and platelets
(thrombocytes). Abnormally high or low counts may be physiological or may indicate disease conditions, and hence need to be interpreted clinically.
The Mentzer index is used to differentiate iron deficiency anaemia beta thalassemia trait. If a CBC indicates microcytic anaemia, these are two of the most likely
causes, making It necessary to distinguish between them.
If the quotient of the mean corpuscular volume divided by the red blood cell count is then 13, thalassemia is more likely. If the result is greater than 13, then iron-
deficiency anaemia is more likely. Green and King Index used to differentiate IDA from thalassemia trait value >65 is likely to be Iron Deficiency Anemia and value <65
Beta Thalassemia Trait. For RDWI Value >220 more likely to be Iron Deficiency Anemia and value <220 more likely to be Beta Thalassemia Trait .
ESR is a non-specific phenomenon, its measurement is clinically useful in disorders associated with an increased production of acute-phase proteins. it provides an
index of progress of the disease in rheumatoid arthritis or tuberculosis, and it is of considerable value in diagnosis of temporal arteritis and polymyalgia rheumatica. It
is often used if multiple myeloma is suspected, but when the myeloma is non-secretory or light chain, a normal ESR does not exclude this diagnosis.
An elevated ESR occurs as an early feature in myocardial infarction. Although a normal ESR cannot be taken to exclude the presence of organic disease, the vast
majority of acute or chronic infections and most neoplastic and degenerative diseases are associated with changes in the plasma proteins that increased ES values.
An increased ESR in subjects who are HIV seropositive seems to be an early predictive marker of progression toward acquired immune deficiency syndrome
(AIDS).
The ESR is influenced by age, stage of the menstrual cycle and medications taken (corticosteroids, contraceptive pills). It is especially low (0–1 mm) in
polycythaemia, hypofibrinogenaemia and congestive cardiac failure and when there are abnormalities of the red cells such as poikilocytosis, spherocytosis, or sickle
cells.
In cases of performance enhancing drug intake by athletes the ESR values are generally lower than the usual value for the individual and as a result of the
increase in haemoglobin (i.e. the effect of secondary polycythaemia).
Page 7 of 9
SIN No:H9091540
Sample Type : Serum Report Status : Final Report
DEPARTMENT OF IMMUNOLOGY
Vitamin B12
VITAMIN B12 782 pg/ml 120 - 914
Method: CLIA
Vitamin B12 is a coenzyme that is involved in two very important metabolic functions vital to normal cell growth and DNA synthesis: 1) the synthesis of methionine,
and 2) the conversion of methylmalonyl CoA to succinyl CoA. Deficiency of this vitamin can lead to megaloblastic anemia and ultimately to severe neurological
problems. Also causes macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective
behavioral changes. A significant increase in RBC MCV may be an important indicator of vitamin B12 deficiency.
Patients taking vitamin B12 supplementation may have misleading results. A normal serum concentration of B12 does not rule out tissue deficiency of vitamin B12 .
The most sensitive test for B12 deficiency at the cellular level is the assay for MMA. If clinical symptoms suggest deficiency, measurement of MMA and
homocysteine should be considered, even if serum B12 concerations are normal.
Vitamin D, 25-Hydroxy
VITAMIN D (25 - OH VITAMIN D) 13.00 ng/ml 30 - 100
Method: CLIA
Biological Reference Ranges:
Deficiency Below 20 ng/ml

Insufficiency 20 - 30 ng/ml
Sufficiency 30 - 100 ng/ml
Toxicity Above 100 ng/ml.
The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.Vitamin D status is best determined by measurement of 25 hydroxy
vitamin D, as it is the major circulating form and has longer half life ( 2-3 weeks) than 1,25 Dihydroxy vitamin D ( 5-8 hrs).
The reference ranges discussed in the preceding are related to total 25-OHD; as long as the combined total is 30 ng/mL or more, the patient has sufficient vitamin D.
Levels needed to prevent rickets and osteomalacia (15 ng/mL) are lower than those that dramatically suppress parathyroid hormone levels (20–30 ng/mL). In turn, those
levels are lower than levels needed to optimize intestinal calcium absorption (34 ng/mL). Neuromuscular peak performance is associated with levels approximately 38
ng/mL.
Page 8 of 9
SIN No:H9091540
DEPARTMENT OF IMMUNOLOGY
Thyroid Profile-Total (T3, T4 & TSH Ultra-sensitive) 1.0

Tri-Iodothyronine (T3, Total) 0.87 ng/ml 0.87 - 1.78
Method: CLIA
Thyroxine (T4, Total) 8.54 ug/dl 5.48 - 14.28
Method: CLIA
Thyroid Stimulating Hormone (TSH)-Ultrasensitive 2.2130 µIU/mL 0.38-5.33
Method: CLIA
*** End Of Report ***
Page 9 of 9
SIN No:H9091540
Terms & Conditions:
1) Machine Data is available for last 7 days only. In case of manual testing & outsourced testing, machine data will not be available.
2) CBC parameters may vary when it is manually reviewed by the Pathologists.
3) For Thyroid tests - Circulating TSH shows a normal circadian rhythm with a peak between 11pm-5am and a nadir between 5pm-8pm. TSH
values are also lowered after food when compared to fasting in a statistically significant manner. This variation is of the order of ±50%, hence
time of day and fasting status have influence on the reported TSH level.
4) For Lipid profile - Lipid and Lipoprotein concentrations vary during the normal course of daily activity. Also, certain drugs, diet and alcohol can
have lasting effects on Triglyceride levels. To obtain best results for Lipid testing, a strict fasting of 10-12 hours with a light meal on the previous
night is recommended.
5) Test results released pertain to the specimen submitted.
6) Test results are dependent on the quality of the sample received by the Lab.
7) The tests are carried out in the lab with the presumption that the specimen belongs to the patient named or identified in the bill/test request
form/booking ID.
8) The reported results are for information and are subject to confirmation and interpretation by the referring doctor to co-relate clinically.
9) Test results may show interlaboratory variations.
10) Liability of Healthians for deficiency of services or other errors and omissions shall be limited to the fee paid by the patient for the relevant
laboratory services.
11) This report is not subject to use for any medico-legal purposes.
12) Few of the tests might be outsourced to partner labs as and when required.

O P Malik

Uploaded by

Copyright:

Available Formats

O P Malik

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

O P Malik

Uploaded by

Copyright:

Available Formats

Patient Name : O P Malik 8348215985 Barcode : H9091540

Age/Gender : 83Y 0M 0D /Male Sample Collected On : 24/Jun/2023 08:04AM

DEPARTMENT OF BIOCHEMISTRY HBA1C

HbA1c - Glycosylated Hemoglobin

Fasting Blood Sugar

Normal : < 100 mg/dl

Lipid Profile 1.0

Liver Function Test 1.0

Kidney Function Test 1.0

Deficiency Below 20 ng/ml

Thyroid Profile-Total (T3, T4 & TSH Ultra-sensitive) 1.0

* End Of Report *

2) CBC parameters may vary when it is manually reviewed by the Pathologists.

5) Test results released pertain to the specimen submitted.

9) Test results may show interlaboratory variations.

You might also like